An outcome-based optimal matching framework is developed to evaluate combination therapy efficacy after adjusting for patient-level heterogeneity, enabling valid inference on cross-world pharmacological interaction effects.
The Promises of Multiple Experiments: Identifying Joint Distribution of Potential Outcomes
3 Pith papers cite this work. Polarity classification is still indexing.
abstract
Typical causal effects are defined based on the marginal distribution of potential outcomes. However, many real-world applications require causal estimands involving the joint distribution of potential outcomes to enable more nuanced treatment evaluation and selection. In this article, we propose a novel framework for identifying and estimating the joint distribution of potential outcomes using multiple experimental datasets. We introduce the assumption of transportability of state transition probabilities for potential outcomes across datasets and establish the identification of the joint distribution under this assumption, along with a regular full-column rank condition. The key identification assumptions are testable in an overidentified setting and are analogous to those in the context of instrumental variables, with the dataset indicator serving as "instrument". Moreover, we propose an easy-to-use least-squares-based estimator for the joint distribution of potential outcomes in each dataset, proving its consistency and asymptotic normality. We further extend the proposed framework to identify and estimate principal causal effects. We empirically demonstrate the proposed framework by conducting extensive simulations and applying it to evaluate the surrogate endpoint in a real-world application.
years
2026 3representative citing papers
An adaptive influence-function framework selects optimal external control subsets to minimize MSE of the ATE estimator in RCTs and adds outcome calibration for better data use.
Formalizes counterfactual individual harm in RL and introduces a two-stage policy learning method with finite-sample guarantees on sub-optimality gap and harm rate control.
citing papers explorer
-
Evaluation of Combination Therapy amid Patient-Level Heterogeneity
An outcome-based optimal matching framework is developed to evaluate combination therapy efficacy after adjusting for patient-level heterogeneity, enabling valid inference on cross-world pharmacological interaction effects.
-
Improving Treatment Effect Estimation in Trials through Adaptive Borrowing of External Controls
An adaptive influence-function framework selects optimal external control subsets to minimize MSE of the ATE estimator in RCTs and adds outcome calibration for better data use.
-
Counterfactually Safe Reinforcement Learning
Formalizes counterfactual individual harm in RL and introduces a two-stage policy learning method with finite-sample guarantees on sub-optimality gap and harm rate control.